Overview

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Novartis Pharmaceuticals
Treatments:
Rivastigmine